Client Instance

HTTP 200 OK
Allow: GET
Content-Type: application/json
Vary: Accept

{
    "id": 210282,
    "url": "https://lda.senate.gov/api/v1/clients/210282/?format=api",
    "client_id": 532,
    "name": "ADAGIO THERAPEUTICS, INC.",
    "general_description": "Virtual pharmaceutical, clinical stage development company",
    "client_government_entity": false,
    "client_self_select": null,
    "state": "MA",
    "state_display": "Massachusetts",
    "country": "US",
    "country_display": "United States of America",
    "ppb_state": "MA",
    "ppb_state_display": "Massachusetts",
    "ppb_country": "US",
    "ppb_country_display": "United States of America",
    "effective_date": "2021-04-15",
    "registrant": {
        "id": 400395867,
        "url": "https://lda.senate.gov/api/v1/registrants/400395867/?format=api",
        "house_registrant_id": 400395867,
        "name": "BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.)",
        "description": "Lobbying and Consulting",
        "address_1": "499 South Capitol St SW # 600",
        "address_2": null,
        "address_3": null,
        "address_4": null,
        "city": "Washington",
        "state": "DC",
        "state_display": "District of Columbia",
        "zip": "20003",
        "country": "US",
        "country_display": "United States of America",
        "ppb_country": "US",
        "ppb_country_display": "United States of America",
        "contact_name": "MARK LINDSAY",
        "contact_telephone": "+1 202-905-7345",
        "dt_updated": "2025-07-21T16:22:26.788059-04:00"
    }
}